Clinically, E-selectin has been found significantly raised in the cerebrospinal fluid (CSF) of AD patients without typical signature biomarker profiles, suggesting it may specifically mark the vascular mechanisms underlying AD pathology (Li et al., 2015). The gene discussed is SELE; the disease is Alzheimer disease.